Center for Scientific Review; Notice of Closed Meetings
Published Date: 2/10/2026
Notice
Summary
The Center for Scientific Review is holding several closed virtual meetings in March 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for cool science projects. If you’re involved in neuroscience, cancer nanotech, or nerve disease research, these reviews could impact your funding timeline and opportunities.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
Closed virtual grant review meetings
The NIH Center for Scientific Review will hold closed virtual meetings on March 10-11, March 12-13, and March 13, 2026 to review and evaluate grant applications for study sections including Neurotoxicology and Alcohol, Cancer Nanotechnology, Guillain-Barré Syndrome/Chronic Inflammatory Demyelinating Polyneuropathy (GBS/CIDP), and Cell Structure and Function. If you are involved in those research areas, these reviews will affect decisions about who receives NIH research funding and could change your funding timeline or opportunities.
Applicant privacy and trade-secret protection
The meetings are closed to the public under Title 5 U.S.C. sections 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, patentable material, commercial property, and personal information in grant applications. This protects applicants' confidential and personal data during the March 2026 virtual review meetings.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13612 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review and decide on important health research grant applications. These meetings keep sensitive info private to protect personal and commercial secrets. Researchers applying for grants and the public can expect no changes in funding timing or amounts, just careful, confidential reviews.
2026-13479 — Government Owned Invention Available for License: Chimeric VLP Vaccines To Prevent HTLV-1 Infection
The National Cancer Institute has created a new vaccine to stop HTLV-1, a virus that can cause serious diseases like leukemia. Right now, no vaccine exists, so this invention could protect millions, especially in underserved areas. They’re looking for partners to help develop and license this promising vaccine, which could save lives and reduce healthcare costs in the near future.
2026-13480 — Government Owned Invention Available for License: A Conserved Viral Peptide for Use in Cancer Immunotherapy
The National Cancer Institute has created a special viral peptide that could help prevent and treat a serious liver cancer called HCC. This new discovery might lead to a vaccine or therapy that boosts the immune system to fight cancer better. Researchers and companies interested in developing this treatment can now license the technology, opening doors for faster progress and potential health benefits worldwide.
2026-13337 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on July 24, 2026, to review and evaluate important grant applications related to cancer, imaging, eye diseases, and reproductive health. These meetings protect private info and trade secrets, so they’re not open to the public. Researchers and organizations applying for grants should note the dates as these reviews impact funding decisions.
2026-13311 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review grant applications and contract proposals. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants or contracts should watch these dates closely, as funding decisions could impact their projects and budgets.
2026-13244 — The Federal Demonstration Partnership; Phase VIII Notice
The Federal Demonstration Partnership (FDP) is inviting colleges, universities, research groups, and hospitals that get federal research money to join its Phase VIII starting in 2027. This phase will keep testing new ways to make research funding and rules easier and faster. Applications are due by September 15, 2026, with the program running through the end of 2032.
Previous / Next Documents
Previous: 2026-02542 — Information Collection: Invoice Submissions by Contractors for NRC Contracts/Orders
The Nuclear Regulatory Commission is renewing its rules for how contractors send in invoices for NRC contracts. If you work with the NRC, you’ll want to check the updated process and share your thoughts by March 12, 2026. This keeps payments smooth and on time, with no new costs expected.
Next: 2026-02544 — National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
The National Institute of Allergy and Infectious Diseases (NIAID) is holding a private meeting from June 8-10, 2026, to review the skills and work of its researchers. This closed meeting affects NIAID staff and helps ensure top-notch science without sharing personal details publicly. No money changes are involved, but the meeting keeps research quality sharp and on track.